US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

70.52

+0.65940.94%

Post-market: 70.520.00000.00%16:10 EDT

Volume:324

Turnover:22.85K

Market Cap:705.23K

PE:- -

High:70.60

Open:70.59

Low:70.43

Close:69.86

52wk High:85.03

52wk Low:55.03

Shares:10.00K

Float Shares:10.00K

Volume Ratio:0.74

T/O Rate:3.24%

Dividend:2.07

Dividend Rate:2.94%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Why GSK May Acquire Nuvalent — Report Points to $9B+ Deal Talks

GlaxoSmithKline in Advanced Talks to Acquire Cancer Drug Developer Nuvalent for Up to $10 Billion

24H | Nuvalent Stock Soars 17% as GSK in Talks to Buy Cancer Biotech Nuvalent for More Than $9Bn

Tiger Newspress

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

MT Newswires Live

GSK Boosts Treasury Stock with Latest Share Buyback Tranche

GSK’s New Pneumococcal Shot Reaches Key Milestone in Midlife Adult Trial

GlaxoSmithKline (GSK) Gets a Buy from Jefferies

GSK boosts treasury stock as buyback lifts voting share base

GSK Emerges as Unexpected Winner From American Oncology Conference -- Market Talk

Analysts Conflicted on These Healthcare Names: GlaxoSmithKline (GB:GSK) and C4 Therapeutics (CCCC)

GlaxoSmithKline (GSK) Gets a Hold from UBS

SBP GROUP (01177) Rises Over 4% as Bepirovirsen Co-developed with GlaxoSmithKline PLC to Unveil Two Phase III Clinical Data at EASL 2026

Sino Biopharm, GSK Report Pivotal Phase III Success for Hepatitis B Drug Bepirovirsen

GSK’s mRNA Flu Vaccine Trial Reaches Key Phase 2 Milestone, Eyeing Next-Gen Seasonal Market

GSK Trial Data Show Functional Cure Rates For Hepatitis B Treatment

MT Newswires Live

Ionis partner GSK reports B-Well 1, B-Well 2 trials meet primary endpoint

GSK Says Hepatitis B Drug Candidate Cured Some Patients in Late-Stage Trials

GSK’s bepirovirsen delivers landmark functional cure rates in chronic hepatitis B phase III trials

Positive Report for GlaxoSmithKline (GSK) from Kepler Capital

GSK’s Long-Acting HIV Study Nears the Finish Line: What Investors Should Watch

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/GSKH/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":70.5163,"timestamp":1788292800000,"preClose":69.8569,"halted":0,"volume":324,"hourTrading":{"tag":"盘后","latestPrice":70.5163,"preClose":70.5163,"latestTime":"16:10 EDT","volume":6,"amount":423.0978,"timestamp":1788293404281,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.009439296619231674,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"Post-Mkt","change":0.6594,"latestTime":"09-01 17:55:17 EDT","open":70.59,"high":70.6,"low":70.43,"amount":22848,"amplitude":0.002434,"askPrice":105.64,"askSize":200,"bidPrice":35.22,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788307200000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":69.8569,"nav":70.443211,"aum":704502.553211,"dividendRate":0.029423,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":70.5163,"preClose":70.5163,"latestTime":"16:10 EDT","volume":6,"amount":423.0978,"timestamp":1788293404281,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.739051,"impliedVol":0.3505,"impliedVolPercentile":0.9906},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.739051,"shares":10001,"dividePrice":2.0748,"high":70.6,"amplitude":0.002434,"preClose":69.8569,"low":70.43,"week52Low":55.03,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":70.5163,"eps":0,"divideRate":0.029423,"volume":324,"delay":0,"ttmEps":0,"open":70.59,"prevYearClose":68.2031,"prevWeekClose":70.5267,"prevMonthClose":69.8569,"prevQuarterClose":73.8574,"fiveDayClose":71.8401,"twentyDayClose":71.5353,"sixtyDayClose":73.2013},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642439454","title":"Why GSK May Acquire Nuvalent — Report Points to $9B+ Deal Talks","url":"https://stock-news.laohu8.com/highlight/detail?id=2642439454","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642439454?lang=en_us&edition=fundamental","pubTime":"2026-06-09 13:58","pubTimestamp":1780984695,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) is reportedly in talks to acquire cancer drugmaker Nuvalent ($NUVL). According to The Financial Times, citing people familia...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-gsk-may-acquire-nuvalent-report-points-to-9b-deal-talks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-gsk-may-acquire-nuvalent-report-points-to-9b-deal-talks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU1829250122.USD","BK4532","BK4585","PCOM","BK4139","BK4539","GSK","NUVL","GSK.UK","GSKH","BK4122","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152613863","title":"GlaxoSmithKline in Advanced Talks to Acquire Cancer Drug Developer Nuvalent for Up to $10 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1152613863","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152613863?lang=en_us&edition=fundamental","pubTime":"2026-06-09 11:34","pubTimestamp":1780976086,"startTime":"0","endTime":"0","summary":"Reports indicate that GlaxoSmithKline PLC (GSK.US) is in advanced discussions to acquire cancer therapy company Nuvalent, Inc. (NUVL.US), with the deal valued between $9 billion and $10...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4588","GSKH","GSK","GSK.UK","NUVL","BK4139","BK4007","LU1829250122.USD","BK4585","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642262458","title":"24H | Nuvalent Stock Soars 17% as GSK in Talks to Buy Cancer Biotech Nuvalent for More Than $9Bn","url":"https://stock-news.laohu8.com/highlight/detail?id=2642262458","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642262458?lang=en_us&edition=fundamental","pubTime":"2026-06-09 09:17","pubTimestamp":1780967831,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nFWN42G141:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GSK in Talks to Buy Cancer Biotech Nuvalent for More Than $9Bn","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999013999.USD","NUVL","LU1228905540.USD","SG9999001176.USD","LU1400636574.HKD","LU1098665638.USD","LU1015430645.USD","LU1400636657.SGD","BK5011","LU0306806265.USD","SG9999001176.SGD","LU1481600234.SGD","LU0203345920.USD","LU0971552673.USD","LU0321505439.SGD","LU0971552830.HKD","LU0225284248.USD","LU0985481810.HKD","LU1302929846.USD","LU1228905037.USD","LU1309081286.SGD","LU1046248800.SGD","LU0289739699.SGD","LU0306807586.USD","LU1983299246.USD","GSK","IE00B3T34201.USD","LU0545562505.USD","SGXZ57979304.SGD","LU2646069778.SGD","LU0211331839.USD","GSKH","LU1064927863.SGD","LU1487256676.USD","LU1645745479.HKD","LU0058720904.USD","LU1202635105.USD","BK4139","LU1670756490.USD","IE0034235071.USD","LU0557290698.USD","LU0109981661.USD","IE00BQJZX424.USD","IE00BWDBJ516.SGD","LU0161305163.EUR","BK4539","LU1481599808.USD","LU0225283273.USD","LU2089984988.USD","LU0225771236.USD","LU0987226296.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641438597","title":"European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2641438597","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641438597?lang=en_us&edition=fundamental","pubTime":"2026-06-08 23:10","pubTimestamp":1780931424,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts kicked off the week higher late Monday morning, lifting 0.82% to 1,874.41 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and biotech firm Evaxion , which rose 7% and 4.5% respectively. They were followed by accommodations booking company trivago  and telecommunications company Nokia , which increased 4.4% and 1.7% respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and biopharmaceutical company Cellectis , which fell 2.9% and 2.3% respectively. They were followed by pharmaceutical company Sanofi  and biopharmaceutical company Grifols , which were down 2% each.The gainers from the UK were led by biopharmaceutical companies Biodexa Pharmaceuticals  and NuCana , which advanced 4.5% and 3.3% respectively. They were followed by oil and gas company BP  and biopharmaceutical company Amarin , which ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0006061336.USD","LU0300736062.USD","BK4020","BP","IE00BFXG1179.USD","CLLS","EVAX","LU0320765646.SGD","BK4141","AUTL","BK4505","GSK.UK","BK4077","BK4585","LU0154236417.USD","LU0300736492.USD","BK4201","LU0162691827.USD","LU1829250122.USD","BK4532","NVOX","GSKH","LU1093756168.USD","GRFS","GSK","BK4208","NCNA","BK4139","NVO","LNOK","BK4547","BK4588","IE00BMPRXR70.SGD","NGG","LU1162221912.USD","BK4599","IE00BZ1G4Q59.USD","LU0072461881.USD","AMRN","BK4007","IE00BMPRXN33.USD","LU1093756325.SGD","NOK","BPH","BDRX","SQNS","TRVG","IE00BKVL7J92.USD","NVOH","MREO","SNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641480300","title":"GSK Boosts Treasury Stock with Latest Share Buyback Tranche","url":"https://stock-news.laohu8.com/highlight/detail?id=2641480300","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641480300?lang=en_us&edition=fundamental","pubTime":"2026-06-08 22:02","pubTimestamp":1780927345,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has shared an announcement. GSK has continued its existing share buyback programme, repurchasing more than 1.6 millio...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-boosts-treasury-stock-with-latest-share-buyback-tranche?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-boosts-treasury-stock-with-latest-share-buyback-tranche?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4007","LU1829250122.USD","BK4532","GSKH","GSK.UK","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641141238","title":"GSK’s New Pneumococcal Shot Reaches Key Milestone in Midlife Adult Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2641141238","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641141238?lang=en_us&edition=fundamental","pubTime":"2026-06-06 00:31","pubTimestamp":1780677068,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has completed a Phase 1 trial titled “A Phase 1, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-pneumococcal-shot-reaches-key-milestone-in-midlife-adult-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-pneumococcal-shot-reaches-key-milestone-in-midlife-adult-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSKH","BK4532","LU1829250122.USD","GSK.UK","GSK","BK4585","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640821661","title":"GlaxoSmithKline (GSK) Gets a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2640821661","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640821661?lang=en_us&edition=fundamental","pubTime":"2026-06-04 05:25","pubTimestamp":1780521915,"startTime":"0","endTime":"0","summary":"Jefferies analyst Michael Leuchten maintained a Buy rating on GlaxoSmithKline today and set a price target of £25.00. According to TipRanks, Leucht...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","GSK","BK4007","LU1829250122.USD","BK4585","BK4588","GSK.UK","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640950348","title":"GSK boosts treasury stock as buyback lifts voting share base","url":"https://stock-news.laohu8.com/highlight/detail?id=2640950348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640950348?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:16","pubTimestamp":1780323389,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) just unveiled an announcement. GSK has continued its share buyback programme, repurchasing just under 1.25 million or...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-boosts-treasury-stock-as-buyback-lifts-voting-share-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-boosts-treasury-stock-as-buyback-lifts-voting-share-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMF","BK4007","GSK","US10Y.BOND","BK4532","GSK.UK","US5Y.BOND","US30Y.BOND","TLTW","US3Y.BOND","US2Y.BOND","US12M.BOND","BK4585","TLT","BK4588","US7Y.BOND","US6M.BOND","GSKH","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640930291","title":"GSK Emerges as Unexpected Winner From American Oncology Conference -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2640930291","media":"Dow Jones","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640930291?lang=en_us&edition=fundamental","pubTime":"2026-06-01 17:53","pubTimestamp":1780307580,"startTime":"0","endTime":"0","summary":"0953 GMT - U.K. drugmaker GSK came out as an unexpected winner from a big U.S. oncology conference, Jefferies analysts say in a note. Early-stage data for GSK's drug candidate IDRx-42 presented at the American Society of Clinical Oncology's annual meeting showed potential as a first-line treatment for gastrointestinal cancer, Jefferies says. Moreover, updates from rivals on new ovarian-cancer drugs didn't top those of GSK's own candidate Mo-Rez, the analysts say. Competition in the market for drugs to treat ovarian cancer resistant to platinum-based chemotherapy is heating up, they add. GSK's Mo-Rez and NaPi2b--developed by Tubulis, which was recently acquired by Gilead Sciences--might be setting the bar for the disease, while AstraZeneca's Puxi-Sam doesn't look as competitive, according to Jefferies. GSK shares fall 0.3%. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","GSKH","BK4588","BK4107","GSK.UK","AFG","BK4585","GSK","BK4117","BK4532","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639606232","title":"Analysts Conflicted on These Healthcare Names: GlaxoSmithKline (GB:GSK) and C4 Therapeutics (CCCC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2639606232","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639606232?lang=en_us&edition=fundamental","pubTime":"2026-05-30 17:02","pubTimestamp":1780131770,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on GlaxoSmithKline (GB:GSK) and C4 Therapeutics (CCCC). GlaxoSmithKl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-glaxosmithkline-gbgsk-and-c4-therapeutics-cccc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-glaxosmithkline-gbgsk-and-c4-therapeutics-cccc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU1829250122.USD","BK4581","GSK","XBI","XLV","BK4137","BK4532","BK4585","CCCC","GSK.UK","LU0029874061.USD","BK4139","HCSG","BK4007","GSKH","LU0128526141.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639693623","title":"GlaxoSmithKline (GSK) Gets a Hold from UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2639693623","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639693623?lang=en_us&edition=fundamental","pubTime":"2026-05-29 17:00","pubTimestamp":1780045236,"startTime":"0","endTime":"0","summary":"UBS analyst Matthew Weston maintained a Hold rating on GlaxoSmithKline today and set a price target of p1,940.00. According to TipRanks, Weston is ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-hold-from-ubs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-hold-from-ubs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0034235071.USD","LU1863844665.USD","GSK.UK","BK4534","LU1829250122.USD","LU3187612489.SGD","GSK","BK4532","GSKH","BK4585","BK4118","BK4007","UBS","LU1863844749.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136878581","title":"SBP GROUP (01177) Rises Over 4% as Bepirovirsen Co-developed with GlaxoSmithKline PLC to Unveil Two Phase III Clinical Data at EASL 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1136878581","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136878581?lang=en_us&edition=fundamental","pubTime":"2026-05-29 14:38","pubTimestamp":1780036715,"startTime":"0","endTime":"0","summary":"SBP GROUP (01177) rose over 4%, up 3.95% at the time of writing, trading at HK$5 with a turnover of HK$428 million. On May 29, SBP GROUP announced that Bepirovirsen, co-developed by its subsidiary,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","IE00BZ08YT58.USD","BK1521","BK4007","HK0000165453.HKD","GSK.UK","LU1829250122.USD","BK4588","III","BK1589","GSK","01177","IE00BZ08YS42.EUR","GSKH","BK4532","BK1515","BK4585","BK1191","IE00BZ08YR35.GBP","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639612379","title":"Sino Biopharm, GSK Report Pivotal Phase III Success for Hepatitis B Drug Bepirovirsen","url":"https://stock-news.laohu8.com/highlight/detail?id=2639612379","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639612379?lang=en_us&edition=fundamental","pubTime":"2026-05-29 07:38","pubTimestamp":1780011524,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical ( ($HK:1177) ) has provided an update. Sino Biopharmaceutical said its subsidiary Chia Tai Tianqing and partner GSK have rep...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sino-biopharm-gsk-report-pivotal-phase-iii-success-for-hepatitis-b-drug-bepirovirsen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sino-biopharm-gsk-report-pivotal-phase-iii-success-for-hepatitis-b-drug-bepirovirsen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSKH","LU1829250122.USD","GSK.UK","BK4532","III","BK4007","BK4588","BK4134","BK4585","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639697287","title":"GSK’s mRNA Flu Vaccine Trial Reaches Key Phase 2 Milestone, Eyeing Next-Gen Seasonal Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2639697287","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639697287?lang=en_us&edition=fundamental","pubTime":"2026-05-29 00:30","pubTimestamp":1779985844,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GSK’s latest update covers a Phase 2a trial titled “A Phase 2a Randomiz...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-mrna-flu-vaccine-trial-reaches-key-phase-2-milestone-eyeing-next-gen-seasonal-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-mrna-flu-vaccine-trial-reaches-key-phase-2-milestone-eyeing-next-gen-seasonal-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LU1829250122.USD","BK4532","GSKH","BK4007","GSK","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638667291","title":"GSK Trial Data Show Functional Cure Rates For Hepatitis B Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2638667291","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638667291?lang=en_us&edition=fundamental","pubTime":"2026-05-28 19:05","pubTimestamp":1779966331,"startTime":"0","endTime":"0","summary":"GSK's  pooled data from two phase 3 clinical trials showed that experimental medicine bepirovirsen achieved a 19% functional cure response rate in individuals with chronic hepatitis B, the drugmaker said Thursday.The therapy reached a 26% cure rate among patients exhibiting lower baseline viral activity compared with no cures in the placebo group, the company said.GSK said it anticipates regulatory approvals in Q3.An exploratory evaluation also indicated nearly half of the participants maintained low surface antigen levels a year after finishing the regimen, GSK said.The medication demonstrated a tolerable safety profile during the trials, with common side effects including temporary liver enzyme elevation and localized injection site pain, GSK said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LU1829250122.USD","GSK","BK4532","GSKH","BK4007","GSK.UK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638696556","title":"Ionis partner GSK reports B-Well 1, B-Well 2 trials meet primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2638696556","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638696556?lang=en_us&edition=fundamental","pubTime":"2026-05-28 17:21","pubTimestamp":1779960078,"startTime":"0","endTime":"0","summary":"Ionis Pharmaceuticals (IONS) partner GSK (GSK) announced data for bepirovirsen, an investigational antisense oligonucleotide for the treatment of c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ionis-partner-gsk-reports-b-well-1-b-well-2-trials-meet-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ionis-partner-gsk-reports-b-well-1-b-well-2-trials-meet-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IONS","BK4532","BK4588","GSKH","BK4585","BK4139","BK4007","GSK","LU1829250122.USD","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638263665","title":"GSK Says Hepatitis B Drug Candidate Cured Some Patients in Late-Stage Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2638263665","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638263665?lang=en_us&edition=fundamental","pubTime":"2026-05-28 16:39","pubTimestamp":1779957540,"startTime":"0","endTime":"0","summary":"GSK said a drug candidate for hepatitis B helped nearly a fifth of patients who enrolled in two late-stage clinical trials achieve a functional cure.The U.K. drugmaker on Thursday released results from two phase 3 trials for the drug, bepirovirsen, which showed 19% of hepatitis B patients achieved a functional cure response rate in the overall study population after a six-month treatment. The drug delivered a functional cure rate of 26% in a smaller group of patients with lower viral activity, the company said.GSK is looking to speed up the launch of the medicines it has in the pipeline, as part of GSK Chief Executive Luke Miels' plan to offset upcoming patent expirations. Miels singled out bepirovirsen in a recent earnings call, saying it would materially change the treatment of hepatitis B.Hepatitis B is a serious liver infection, which can lead to liver damage, cancer and death. GSK said the drug has potential to redefine the treatment of a disease for which the current standard of ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSKH","BK4585","GSK","GSK.UK","SSI","BK4007","BK4532","LU1829250122.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638766503","title":"GSK’s bepirovirsen delivers landmark functional cure rates in chronic hepatitis B phase III trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2638766503","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638766503?lang=en_us&edition=fundamental","pubTime":"2026-05-28 16:32","pubTimestamp":1779957142,"startTime":"0","endTime":"0","summary":"An update from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK reported pivotal phase III data showing its investigational antisense oligonucle...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-bepirovirsen-delivers-landmark-functional-cure-rates-in-chronic-hepatitis-b-phase-iii-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-bepirovirsen-delivers-landmark-functional-cure-rates-in-chronic-hepatitis-b-phase-iii-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","GSK","BK4585","BK4532","BK4007","III","LU1829250122.USD","BK4588","BK4134","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638634636","title":"Positive Report for GlaxoSmithKline (GSK) from Kepler Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2638634636","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638634636?lang=en_us&edition=fundamental","pubTime":"2026-05-28 15:55","pubTimestamp":1779954956,"startTime":"0","endTime":"0","summary":"In a report released on May 26, Nicolas Pauillac from Kepler Capital upgraded GlaxoSmithKline to a Buy, with a price target of p2,516.00. According...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/positive-report-for-glaxosmithkline-gsk-from-kepler-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/positive-report-for-glaxosmithkline-gsk-from-kepler-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4532","GSKH","GSK.UK","GSK","LU1829250122.USD","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638486682","title":"GSK’s Long-Acting HIV Study Nears the Finish Line: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2638486682","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638486682?lang=en_us&edition=fundamental","pubTime":"2026-05-28 00:30","pubTimestamp":1779899412,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline (through ViiV Healthcare) has completed a Phase 3b stud...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-long-acting-hiv-study-nears-the-finish-line-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-long-acting-hiv-study-nears-the-finish-line-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4581","GSKH","BK4585","BK4211","XLV","XBI","BK4532","GSK.UK","LU1829250122.USD","BK4007","GSK","ISBC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}